Gates Foundation

Activity from announced rounds

Activity in this selectionBiotech
Rounds participated in
5
Confirmed lead rounds
—
5 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$178.3M
5 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Series A1
Series B1

By primary sector

Biotech3
Agritech1
AI1

By country

United States4
Netherlands1

Rounds

5 in this selection
ProFound Therapeutics

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

$35MStrategic
Role not disclosed
Leyden Laboratories

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

€40MSeries B
Role not disclosed
Kanvas Biosciences

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A
Role not disclosed
Ten63 Therapeutics

Develops AI-driven drug discovery platform for first- and best-in-class therapeutics

$45MStrategic
Role not disclosed
Heritable Agriculture

Develops AI-driven crop improvement solutions for climate-resilient crops

$5MGrant
Role not disclosed